New model may help predict survival in breast cancer patients with brain lining spread

NCT ID NCT07386886

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 403 breast cancer patients whose cancer had spread to the lining of the brain and spinal cord. Researchers collected detailed medical information to understand what factors affect survival. They used this data to create a new scoring system that could help doctors predict how long patients might live and guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a better way to predict outcomes for breast cancer patients with leptomeningeal metastasis, helping doctors tailor treatment.

What could go wrong

This is an observational study, not a treatment trial. The new model needs further testing in other groups before it can be widely used.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS IN BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplastic meningitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.